Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Moph: Prevention Guidance following the Storm Repercussions

 
The Information office of the Ministry of Public Health issued the following statement:

In anticipation of the upcoming storms that will hit Lebanon, and in the light of its awareness-raising tasks, the Ministry of Public Health issued the following guidelines to ensure the safety of the citizens.
  • Follow the safety standards while using heating appliances, in particular at night to prevent any gas leak or fire.
  • Equip your houses with fire extinguishers.
  • Avoid moving between cold and hot areas and drink plenty of fluids to prevent dehydration.
  • People with heart diseases, asthma or obstructive pulmonary are advised not to leave home to avoid exposure to cold air that might cause health problems.
  • Store sufficient quantities of medicines for all the period of the storm.
For more information on the protection from accidents caused by heating appliances, read the following guidelines on children protection.
 
Heating:
  • When using an electric heater, check the electric cables to avoid any electrical fire
  • When using a gas heater, check the gas hose for any gas leak
  • When using  coal – wood – diesel heaters, the following should be considered:
 
  • Don’t allow children to contact or play with the flame to prevent burns, accidents and suffocation
  • Equip your houses with fire extinguishers, fire blanket and  a smoke detector (if possible)
  • Keep the heater far from diesel tanks
  • Ensure flammable items are kept away from the heating appliances (curtains, blankets…)
  • Don’t keep the clothes close to heating appliances to dry them 
Personal prevention tips:
  • Avoid exposing your back and neck to cold air and wear suitable clothes
  • Avoid moving between cold and hot areas
  • Drink plenty of water and fluids to prevent dehydration
  • Turn off your home’s electricity in the event of flooded home 
People with chronic diseases:
  • People with asthma or obstructive pulmonary are advised not to leave home during the storm
  • People with heart diseases are advised to stay home since cold air can cause vessels/ coronary arteries to narrow, which can lead to a pain in the chest
  • Store sufficient quantities of medicines for all the period of the storm. 
Tips for children

Clothing:
  • Dress your infants and children in warm clothes, in particular when going outside. Don’t forget winter accessories such as gloves and hat. Dress babies and young children in one more layer of clothing than an adult would wear in the same conditions.
  • blankets, quilts, pillows can cause Sudden Infant death syndrome 
  • Hypothermia
  • Hypothermia is a drop in body temperature caused by exposure to cold temperatures. It usually occurs when children play outside in extremely cold weather without wearing appropriate clothes or when clothes are wet.
  • Symptoms are shivering, mumbling, very low energy and even loss of consciousness. In such a case, bring the child indoors, remove any wet clothes, wrap with blanket or warm clothes and contact the doctor if need be. 
Frostbite
Frostbite occurs when cold causes extremities to freeze, such as fingers, feet, ears and nose which may become white or blue, or may itch or burn.

In case of frostbite, the child should be brought indoors and his injured parts should be put in warn water. Warm towels can also be applied to nose, ears and lips. Do not to rub the frozen area surfaces. A few minutes later, give the child warm fluids to drink. If numbness persisted more than a couple of minutes, contact your doctor.
 
    ...
    65
    ...
ATC Name B/G Ingredients Dosage Form Price
L01FG01 STIVANT BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable concentrate for solution 14,719,570 L.L
L01FG01 ZIRABEV BioTech Bevacizumab - 100mg/4ml 100mg/4ml Injectable solution 14,800,115 L.L
L01FG02 CYRAMZA BioTech Ramucirumab - 100mg/10ml 100mg/10ml Injectable solution 47,779,251 L.L
L01FG02 CYRAMZA BioTech Ramucirumab - 500mg/50ml 500mg/50ml Injectable solution 218,656,548 L.L
L01FX02 MYLOTARG BioTech Gemtuzumab Ozogamicin - 4.5mg 4.5mg Injectable powder 748,160,090 L.L
L01FX04 YERVOY BioTech Ipilimumab - 50mg/10ml 50mg/10ml Injectable solution 332,262,937 L.L
L01FX05 ADCETRIS BioTech Brentuximab Vedotin - 50mg 50mg Injectable powder for concentrate for solution 298,266,862 L.L
L01FX07 BLINCYTO BioTech Blinatumomab - 35mcg 35mcg Injectable lyophilised powder for solution+stabilizer 239,484,334 L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable lyophilised powder for solution+diluent 52,297,174 L.L
L01FX18 RYBREVANT BioTech Amivantamab - 350mg 350mg Injectable concentrate for solution 135,818,621 L.L
R03DX05 XOLAIR BioTech Omalizumab - 150mg 150mg Injectable solution 37,110,724 L.L
A16AB04 FABRAZYME BioTech Agalsidase beta - 35mg 35mg Injectable powder for concentrate for solution 295,038,213 L.L
L01FX24 TECVAYLI BioTech Teclistamab - 10mg/ml 10mg/ml Injectable solution 95,166,436 L.L
L01FX24 TECVAYLI BioTech Teclistamab - 90mg/ml 90mg/ml Injectable solution 483,720,518 L.L
A16AB07 MYOZYME BioTech Alglucosidase alfa, recombinant human acid - 50mg 50mg Injectable powder for concentrate for solution 54,382,728 L.L
N02CD01 AIMOVIG BioTech Erenumab - 70mg/ml 70mg/ml Injectable solution 35,423,371 L.L
N02CD02 EMGALITY BioTech Galcanezumab - 120mg/ml 120mg/ml Injectable suspension 37,250,732 L.L
B01AB05 ENOMEX BioTech Enoxaparin sodium - 4000U Anti-Xa/0.4ml 4000U Anti-Xa/0.4ml Injectable solution 753,832 L.L
B01AB05 ENOXA MEDIS BioTech Enoxaparin sodium - 4,000U Anti-Xa/0.4ml 4,000U Anti-Xa/0.4ml Injectable solution 755,239 L.L
B01AB05 ENOXAMED BioTech Enoxaparin sodium - 4000IU Anti-XA/0.4ml 4000IU Anti-XA/0.4ml Injectable solution 755,239 L.L
B01AB05 ENOXAMED BioTech Enoxaparin sodium - 4000IU Anti-XA/0.4ml 4000IU Anti-XA/0.4ml Injectable solution 2,150,148 L.L
B01AB05 ENOXAPARIN LEDRAXEN BioTech Enoxaparin sodium - 4000UI (40mg)/0.4ml 4000UI (40mg)/0.4ml Injectable solution 841,245 L.L
B01AB05 HEPAXANE 4000IU BioTech Enoxaparin sodium - 40mg/0.4ml 40mg/0.4ml Injectable solution 4,063,780 L.L
S01LA04 LUCENTIS BioTech Ranibizumab - 10mg/ml 10mg/ml Injectable solution 51,255,093 L.L
B01AB05 LOVENOX BioTech Enoxaparin sodium - 4,000UI (40mg)/0.4ml 4,000UI (40mg)/0.4ml Injectable solution 886,936 L.L
S01LA05 EYLEA BioTech Aflibercept - 40mg/ml 40mg/ml Injectable solution 65,161,855 L.L
B01AB05 PARINOX 40 BioTech Enoxaparin sodium - 4000IU (40mg)/0.4ml 4000IU (40mg)/0.4ml Injectable solution 358,358 L.L
S01LA05 EYLEA BioTech Aflibercept - 8mg/0.07ml 8mg/0.07ml Injectable solution 75,348,607 L.L
B01AB05 ENOMEX BioTech Enoxaparin sodium - 8000U Anti-Xa/0.8ml 8000U Anti-Xa/0.8ml Injectable solution 1,025,160 L.L
S01LA06 BEOVU BioTech Brolucizumab - 120mg/ml 120mg/ml Injectable solution 68,669,378 L.L
    ...
    65
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025